Opti Capital Management, LP Quant / Systematic

Location: New York, NY

CIK: 0001738654 · Show all filings

Period: Q4 2021 (← Previous) (Next →)

Filing Date: Feb 14, 2022

Total Value: $1.319B (0.0% shares, 100.0% debt)

Holdings (37)

DICKS SPORTING GOODS INC 8.0%
Value $105M Shares 29,655,000 Est. Cost $3.09 Unrealized
NATERA INC 7.3%
Value $96.16M Shares 37,362,000 Est. Cost $3.03 Unrealized
ZSCALER INC 6.8%
Value $90.16M Shares 41,140,000 Est. Cost $2.19 Unrealized
CONMED CORP 6.1%
Value $80.15M Shares 48,065,000 Est. Cost $1.62 Unrealized
ETSY INC 5.3%
Value $70.24M Shares 27,500,000 Est. Cost $2.55 Unrealized
WORKIVA INC 5.2%
Value $69.18M Shares 39,038,000 Est. Cost $1.85 Unrealized
NOVA LTD 3.7%
Value $48.23M Shares 24,260,000 Est. Cost $1.99 Unrealized
SUPERNUS PHARMACEUTICALS 3.4%
Value $45.15M Shares 45,402,000 Est. Cost $1.63 Unrealized
SAILPOINT TECHNOLOGIES HLDGS 3.4%
Value $44.25M Shares 24,780,000 Est. Cost $1.84 Unrealized
8X8 INC NEW 3.1%
Value $40.76M Shares 40,575,000 Est. Cost $1.00 Unrealized
VEECO INSTRS INC DEL 3.1%
Value $40.52M Shares 18,500,000 Est. Cost $1.78 Unrealized
IONIS PHARMACEUTICALS INC 2.9%
Value $38.38M Shares 42,438,000 Est. Cost $0.96 Unrealized
ENVESTNET INC 2.9%
Value $37.91M Shares 30,000,000 Est. Cost $1.26 Unrealized
INSIGHT ENTERPRISES INC 2.8%
Value $37.49M Shares 23,336,000 Est. Cost $1.51 Unrealized
PEGASYSTEMS INC 2.8%
Value $36.58M Shares 34,230,000 Est. Cost $1.11 Unrealized
NEW RELIC INC 2.7%
Value $36M Shares 30,000,000 Est. Cost $1.16 Unrealized
AVAYA HLDGS CORP 2.5%
Value $32.66M Shares 30,695,000 Est. Cost $1.06 Unrealized
MANDIANT INC 2.4%
Value $31.39M Shares 31,309,000 Est. Cost $2.01 Unrealized
KBR INC 2.3%
Value $30.57M Shares 16,000,000 Est. Cost $1.57 Unrealized
VONAGE HLDGS CORP 2.2%
Value $29.34M Shares 21,880,000 Est. Cost $1.10 Unrealized
RAMBUS INC DEL 2.2%
Value $28.38M Shares 18,000,000 Est. Cost $1.46 Unrealized
NATIONAL VISION HLDGS INC 2.1%
Value $27.95M Shares 16,591,000 Est. Cost $1.76 Unrealized
REPLIGEN CORP 1.9%
Value $24.75M Shares 10,534,000 Est. Cost $2.53 Unrealized
ZENDESK INC 1.8%
Value $23.96M Shares 20,000,000 Est. Cost $1.20 Unrealized
FORTIVE CORP 1.7%
Value $21.95M Shares 21,927,000 Est. Cost $1.00 Unrealized
ALTERYX INC 1.6%
Value $20.88M Shares 22,081,000 Est. Cost $0.95 Unrealized
NUVASIVE INC 1.5%
Value $20.14M Shares 19,910,000 Est. Cost $1.05 Unrealized
COHERUS BIOSCIENCES INC 1.5%
Value $19.67M Shares 17,650,000 Est. Cost $1.03 Unrealized
HESKA CORP 1.1%
Value $14.96M Shares 6,616,000 Est. Cost $2.26 Unrealized
MODEL N INC 1.1%
Value $14.06M Shares 12,000,000 Est. Cost $1.27 Unrealized
KARYOPHARM THERAPEUTICS INC 0.9%
Value $12.23M Shares 14,960,000 Est. Cost $1.03 Unrealized
MANDIANT INC 0.8%
Value $10.68M Shares 10,216,000 Est. Cost $1.05 Unrealized
LENDINGTREE INC 0.7%
Value $9.588M Shares 11,500,000 Est. Cost $0.84 Unrealized
BIOMARIN PHARMACEUTICAL INC 0.6%
Value $8.56M Shares 8,095,000 Est. Cost $1.04 Unrealized
PTC THERAPEUTICS INC 0.6%
Value $8.505M Shares 8,000,000 Est. Cost $2.51 Unrealized
VIAVI SOLUTIONS INC 0.5%
Value $6.512M Shares 4,596,000 Est. Cost $1.34 Unrealized
OMEROS CORP 0.4%
Value $5.598M Shares 6,100,000 Est. Cost $1.71 Unrealized